Quantcast
Last updated on April 20, 2014 at 8:23 EDT

Latest Cancer Research Stories

2013-10-22 16:25:34

MECHELEN, Belgium and LAUSANNE, Switzerland, October 22, 2013 /PRNewswire/ -- Biocartis also introduces IdyllaTM, the brand name for its innovative and high-quality diagnostic platform (previously codenamed Apollo). IdyllaTM is designed to carry out fast and accurate analysis of a broad range of clinical samples[1]. The platform retains the sensitivity of existing technologies but overcomes, amongst others, the current time-consuming testing process of tumour samples....

2013-10-22 08:33:44

DURHAM, N.C., Oct. 22, 2013 /PRNewswire/ -- CureCancerStarter.org, one of the first websites to connect cancer patients, their friends and family to cancer researchers, launched today. (Photo: http://photos.prnewswire.com/prnh/20131022/PH01403-a) (Logo: http://photos.prnewswire.com/prnh/20131022/PH01403LOGO-b) CureCancerStarter.org, a 501c3 nonprofit, features cancer research from the University of North Carolina Lineberger Comprehensive Cancer Center (Chapel Hill, NC), The Duke...

2013-10-21 13:17:16

LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October...

2013-10-21 08:29:56

EATONTOWN, N.J., Oct. 21, 2013 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") announced the immediate availability of Tetracycline HCl Capsules, USP in 250 and 500 mg strengths. This product is the AB rated generic equivalent to the antibiotic Achromycin V and adds to Heritage's robust portfolio of generic oral solid products. Tetracycline capsules have been on the FDA drug shortage list for the past two years and Heritage is the first generic pharmaceutical manufacturer...

2013-10-21 08:29:23

Extension of Progression-Free Survival Observed Compared to Last Prior Therapy SAN DIEGO, Oct. 21, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced results from a Phase I first-in-human, single-agent clinical study of its investigational mitochondrial inhibitor drug candidate, ME-344, in patients with refractory solid tumors. The results, presented yesterday at the AACR-NCI-EORTC...

2013-10-20 23:03:15

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new technique developed by scientists that allows cancer treatments to gain access to the brain. New York, NY (PRWEB) October 20, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new way for cancer treatments to access the brain, increasing their effectiveness. According to an October 17, 2013 article published by The...

2013-10-19 23:03:04

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses discovery of a potential new role for DNA in the prevention of brain tumors. New York, NY (PRWEB) October 19, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a potential new role for DNA in the prevention of brain tumors. According to an October 10, 2013 article published by Cancer Research UK titled “New Role for DNA...

2013-10-18 23:02:37

The 6th Annual Turning up the Heat for Brain Tumors Chili Cook-off in Lake Mary, FL raises funds and awareness for the Chris Elliott Fund. Lake Mary, FL (PRWEB) October 18, 2013 This year marks the 6th Annual Turning Up the Heat on Brain Tumors Chili Cook-off to raise money for brain cancer patient support and research for the Chris Elliott Fund. The cook-off will be held at the Mike Bender Golf Academy, at the Magnolia Plantation Golf Club in Lake Mary, Florida on Sunday, November 10th,...

2013-10-18 08:24:29

-- Collaboration will Assemble and Validate a Tumor Antigen-Associated (TAA) Autoantibody Biomarker Panel for Tumor Characterization and Cancer Immunotherapy -- SAN DIEGO, Oct. 18, 2013 /PRNewswire/ -- Genalyte, Inc., today announced that it has received a $1 million SBIR grant from the National Cancer Institute (NCI) to develop a biomarker panel to profile tumor antigen-associated (TAA) autoantibodies. The panel will run on Genalyte's multiplexed Maverick(TM) Detection System,...

2013-10-17 23:02:41

In an effort to strengthen the Hispanic pipeline in the healthcare and biomedical industries, City of Hope's sponsorship provides the opportunity for the organization to recruit prime Hispanic candidates. Duarte, CA (PRWEB) October 17, 2013 As part of its outreach and recruitment efforts to the fast-growing United States Hispanic community, City of Hope, a leading global research and treatment center for cancer, diabetes, and other life-threatening diseases, is sponsoring a College...